Made in Singapore anti-diabetic drug could be available in three years (translated)
SINGAPORE, October 23, 2016 /Lianhe Zaobao/ —
Article by Cai Xinying
This article highlighted that the “made in Singapore” anti-diabetic drug, DAA-I, has successfully completed its stage I clinical trial. The drug is a result of 20 years of extensive research and was a joint collaboration between NUS Yong Loo Lin School of Medicine, SCRI and the NUHS. The article also covered key points on the drug’s mechanism and its benefits over current treatment for diabetes, as well as future plans for the development of the drug.
A photo of Associate Professor Teoh, Associate Professor Sim and Professor Lee was also featured in the print article.
Click here to view the online article (in Mandarin).